Acadia Pharmaceuticals (ACAD) Amortizatization of Intangibles (2011 - 2026)
Acadia Pharmaceuticals' quarterly Amortizatization of Intangibles came in at $2.7 million in Q1 2026, up 28.64% year-on-year from $2.1 million in Q1 2025, and up 199.23% quarter-over-quarter from -$2.7 million in Q4 2025.
Acadia Pharmaceuticals has reported Amortizatization of Intangibles for 16 years, with the latest figure at $2.7 million in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 28.64% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (down 54.04% YoY), and the FY2025 full-year result was $5.4 million, down 63.75% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $2.7 million, up from -$2.7 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $5.0 million in Q4 2024, with the low at -$2.7 million in Q4 2025.
- Average Amortizatization of Intangibles over 5 years is $1.6 million, with a median of $2.1 million recorded in 2025.
- Peak annual rise in Amortizatization of Intangibles reached 848.44% in 2023, while the deepest fall reached 302.01% in 2023.
- Tracing ACAD's Amortizatization of Intangibles over 5 years: stood at -$642000.0 in 2022, then soared by 848.44% to $4.8 million in 2023, then climbed by 3.81% to $5.0 million in 2024, then slumped by 154.99% to -$2.7 million in 2025, then jumped by 199.23% to $2.7 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $2.7 million (Q1 2026), -$2.7 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | 2.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.72 Mn |
| Mar 31, 2026 | 2.72 Mn |
| Dec 31, 2025 | -2.74 Mn |
| Dec 31, 2025 | -2.74 Mn |
| Sep 30, 2025 | 2.70 Mn |
| Sep 30, 2025 | 2.70 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 2.12 Mn |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 4.99 Mn |
| Dec 31, 2024 | 4.99 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 2.30 Mn |
| Mar 31, 2024 | 1.79 Mn |
| Mar 31, 2024 | 1.79 Mn |
| Dec 31, 2023 | 4.81 Mn |
| Dec 31, 2023 | 4.81 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | -903,000.00 |
| Jun 30, 2023 | -903,000.00 |
| Mar 31, 2023 | 2.27 Mn |
| Mar 31, 2023 | 2.27 Mn |
| Dec 31, 2022 | -642,000.00 |
| Dec 31, 2022 | -642,000.00 |
| Sep 30, 2022 | 642,000.00 |
| Sep 30, 2022 | 642,000.00 |
| Jun 30, 2022 | 447,000.00 |
| Jun 30, 2022 | 447,000.00 |
| Mar 31, 2022 | -447,000.00 |
| Mar 31, 2022 | -447,000.00 |
| Dec 31, 2021 | -3.51 Mn |
| Dec 31, 2021 | -3.51 Mn |
| Sep 30, 2021 | 400,000.00 |
| Sep 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 400,000.00 |
| Mar 31, 2021 | 370,000.00 |
| Mar 31, 2021 | 370,000.00 |
| Dec 31, 2020 | 377,000.00 |
| Dec 31, 2020 | 377,000.00 |
| Sep 30, 2020 | 400,000.00 |
| Sep 30, 2020 | 400,000.00 |
| Jun 30, 2020 | 400,000.00 |
| Jun 30, 2020 | 400,000.00 |
| Mar 31, 2020 | -87,000.00 |
| Mar 31, 2020 | -87,000.00 |
| Dec 31, 2019 | 369,000.00 |
| Dec 31, 2019 | 369,000.00 |
| Sep 30, 2019 | 400,000.00 |
| Sep 30, 2019 | 400,000.00 |
| Jun 30, 2019 | 400,000.00 |
| Jun 30, 2019 | 400,000.00 |
| Mar 31, 2019 | 370,000.00 |
| Mar 31, 2019 | 370,000.00 |
| Dec 31, 2018 | 307,000.00 |
| Dec 31, 2018 | 307,000.00 |
| Sep 30, 2018 | 400,000.00 |
| Sep 30, 2018 | 400,000.00 |
| Jun 30, 2018 | 400,000.00 |
| Jun 30, 2018 | 400,000.00 |
| Mar 31, 2018 | 369,000.00 |
| Mar 31, 2018 | 369,000.00 |
| Dec 31, 2017 | -817,000.00 |
| Dec 31, 2017 | -817,000.00 |
| Sep 30, 2017 | 400,000.00 |
| Sep 30, 2017 | 400,000.00 |
| Jun 30, 2017 | 400,000.00 |
| Jun 30, 2017 | 400,000.00 |
| Mar 31, 2017 | 113,000.00 |
| Mar 31, 2017 | 113,000.00 |
| Dec 31, 2016 | -704,000.00 |
| Dec 31, 2016 | -704,000.00 |
| Sep 30, 2016 | 369,000.00 |
| Sep 30, 2016 | 369,000.00 |
| Jun 30, 2016 | 246,000.00 |
| Jun 30, 2016 | 246,000.00 |
| Mar 31, 2016 | 234,000.00 |
| Mar 31, 2016 | 234,000.00 |
| Dec 31, 2015 | -1.90 Mn |
| Dec 31, 2015 | -1.90 Mn |
| Sep 30, 2015 | 787,000.00 |
| Sep 30, 2015 | 787,000.00 |
| Jun 30, 2015 | 826,000.00 |
| Jun 30, 2015 | 826,000.00 |
| Mar 31, 2015 | 289,000.00 |
| Mar 31, 2015 | 289,000.00 |
| Dec 31, 2014 | 345,000.00 |
| Dec 31, 2014 | 345,000.00 |
| Sep 30, 2014 | -356,000.00 |
| Sep 30, 2014 | -356,000.00 |
| Jun 30, 2014 | 322,000.00 |
| Jun 30, 2014 | 322,000.00 |
| Mar 31, 2014 | -311,000.00 |
| Mar 31, 2014 | -311,000.00 |
| Dec 31, 2013 | -590,000.00 |
| Dec 31, 2013 | -590,000.00 |
| Sep 30, 2013 | -465,000.00 |
| Sep 30, 2013 | -465,000.00 |
| Jun 30, 2013 | -328,000.00 |
| Jun 30, 2013 | -328,000.00 |
| Mar 31, 2013 | -145,000.00 |
| Mar 31, 2013 | -145,000.00 |
| Dec 31, 2012 | -28,000.00 |
| Dec 31, 2012 | -28,000.00 |
| Sep 30, 2012 | 5,000.00 |
| Sep 30, 2012 | 5,000.00 |
| Jun 30, 2012 | 77,000.00 |
| Jun 30, 2012 | 77,000.00 |
| Mar 31, 2012 | 79,000.00 |
| Mar 31, 2012 | 79,000.00 |
| Dec 31, 2011 | 136,000.00 |
| Dec 31, 2011 | 136,000.00 |
| Sep 30, 2011 | -22,000.00 |
| Sep 30, 2011 | -22,000.00 |
| Jun 30, 2011 | -68,000.00 |
| Jun 30, 2011 | -68,000.00 |
| Mar 31, 2011 | -151,000.00 |
| Mar 31, 2011 | -151,000.00 |